Reach Us +1-947-333-4405
Early Occurrence And Recurrence Of Hepatocellular Carcinoma In Hepatitis C Virus Related Cirrhosis Treated With Direct-acting Antivirals | 109229
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus related cirrhosis treated with direct-acting antivirals

Joint Event on 2nd International Conference on Tropical and Infectious Diseases & 14th International Conference on Allergy and Clinical Immunology

Ghweil Ali Abdelrahman

South Valley University, Egypt

ScientificTracks Abstracts: J Infect Dis Ther

Introduction & Objective: Hepatitis C Virus (HCV) infection is a major leading cause of chronic hepatitis, liver cirrhosis and Hepatocellular Carcinoma (HCC). The new Direct-Acting Antivirals (DAAs) are very effective and well-tolerated with achievement of sustained virological response rates in more than 90% of patients with HCV infection. However, several studies have raised concerns about the risk of HCC in HCV patients treated with Interferon (IFN)-free DAA-based therapy, although other studies have failed to support these results. The objective of the study is to detect the association between DAA exposure and HCC occurrence and early recurrence in HCV-related liver cirrhosis.

Method: A follow up study was conducted on 200 patients with HCV infection treated with DAA-based therapy. Abdomen ultrasonography was performed before treatment and 3 months after treatment.

Results: HCC was found in 11 patients (5.5%) after. Recurrence was found in 6/20 patients (30%) who had previous history of HCC while de novo HCC occurrence was found in 5/180 patients (2.78%). Liver fibrosis, previous history of HCC and lower platelet count had significant, independent association with HCC recurrence.

Conclusion: It is difficult to treatment say if DAA had an influence on the appearance of HCC. A close followup with ultrasonography is necessary. Multicenter studies with greater sample size are essential to clarify this issue.

Ghweil Ali Abdelrahman was a Resident of (Tropical medicine and Gastroenterology) for three years .He worked as a Clinical demonstrator and assistant lecturer of Tropical medicine and Gastroenterology, Sohag University. He was working as a Lecturer of Tropical medicine and Gastroenterology, South Valley University. Currently, he is the Head of Tropical Medicine and Gastroenterology department, South Valley University. He is also a member of the European Society of Liver Diseases (EASL).